Composition for preventing, alleviating or treating respiratory diseases, containing siraitia grosvenorii extract as active ingredient
Respiratory diseases, technology of active ingredients, applied in the field of compositions for preventing, improving or treating respiratory diseases containing Luo Han Guo extract as an active ingredient, achieving the effects of reduced tissue damage, excellent inflammation inhibitory activity, useful use
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Embodiment 1. prepares Luo Han Guo extract
[0033] After pulverizing 200 g of dried Luo Han Guo, 2 liters of water were added to carry out reflux extraction for 3 hours. After filtering the extract, 1 liter of 70% (v / v) ethanol was added to 50 g of the dried residue obtained by drying the remaining residue, followed by reflux extraction for 3 hours. After filtering the extract, concentrate and dry to prepare the Luo Han Guo residue extract.
Embodiment 2
[0034] Example 2. Analysis of respiratory hyperresponsiveness according to administration of Luo Han Guo residue extract using an animal model of asthma.
[0035] Experiments were performed using an animal model of bronchial asthma induced by ovalbumin. Experimental animals were 7-week-old Balb / c mice provided by Jackson Laboratory (Bar Harbor, ME, USA), which were adapted for 1 week before being used in experiments. 0.26 mg of aluminum hydroxide (A8222, Sigma-Aldrich Company, Missouri (MO), USA) and 12.5 μg of aluminum hydroxide (A5503, Sigma-Aldrich Company) suspended in the abdominal cavity were injected into the abdominal cavity at intervals of 2 weeks to acclimated mice for 1 week. Ovalbumin in 0.25ml of phosphate buffer solution to sensitize it. On the 3rd and 10th days after the first intraperitoneal administration of ovalbumin, after intratracheal injection (intratracheal injection) of 2 mg of ovalbumin to mice, within 4 weeks from the 21st day, use an ultrasonic nebu...
Embodiment 3
[0042] Example 3. Confirmation of the reduction effect of inflammatory cells in bronchoalveolar lavage fluid after administration of Luo Han Guo residue extract to an asthma animal model
[0043] At a time point of 48 hours after the last exposure to ovalbumin in the ovalbumin-exposed animal model, the mice were anesthetized and bronchiectomized. The bronchoalveoli were washed with 1.0 ml of ice-cold (Ice-cold) DMEM medium and the washing solution was collected. Immediately after recovery, the bronchoalveolar washing fluid of each individual was centrifuged to separate blood cells. After staining with 0.04% trypan blue, the total cell number was counted with a hematocytometer, and then coated with a cytocentrifuge. After the Cytospin was used to smear the specimens, Diff-Quick staining (Romanowsky stain (Romanowsky stain)) was carried out, and a 400-fold optical microscope (Lightmicroscope, Nikon (Nikon) Co., Ltd., Japan) ) to identify and count eosinophils and other inflamma...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com